# PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy

> **NCT02644694** · PHASE1 · COMPLETED · sponsor: **Eyegate Pharmaceuticals, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Vitrectomy

## Interventions

- **DRUG:** Dexamethasone Phosphate Ophthalmic Solution

## Key facts

- **NCT ID:** NCT02644694
- **Lead sponsor:** Eyegate Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-10
- **Final completion:** 2016-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644694, "PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02644694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*